Lumiata
Lumiata is a McLean, Virginia-based healthcare AI company that operates a value-based kidney and heart care management platform, serving health plans, providers, and patients through risk-sharing contracts and a proprietary decision-support technology.
- Company typePrivate
- Founded2013
- HeadquartersMclean, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Lumiata does
Lumiata is a private healthcare technology company headquartered in McLean, Virginia, founded in 2013, that operates a value-based care platform targeting kidney and heart disease management. The company describes itself as driving "predictability and precision at scale" to help healthcare organizations reduce risk and manage costs using AI-enabled decision support. It serves three primary stakeholder groups: patients managing chronic kidney and heart conditions who receive clinical, emotional, and social support; healthcare providers including nephrologists, cardiologists, and care teams seeking to extend their capabilities; and health insurance plans seeking to reduce hospitalization costs and improve member outcomes.
The core product is the proprietary RenalIQ technology platform, which supports intelligent decision-making across the kidney and heart care continuum and integrates with health plan and provider workflows. Lumiata complements this technology with local, hands-on health support teams that deliver individualized clinical, emotional, and social interventions, and offers a self-serve patient portal for direct member engagement. The company holds NCQA Health Equity Accreditation across Case Management, Population Health Program, and Health Equity, as well as HITRUST CSF certification, which serve as procurement prerequisites for many enterprise health plan customers. Revenue is generated through value-based contracts with health plans, where pricing is not publicly disclosed but contracts are structured around shared financial risk and outcome-based economics rather than per-seat licensing. The go-to-market is primarily direct enterprise sales to health plans and provider systems, supplemented by content marketing, webinars, and social media presence for top-of-funnel awareness. Lumiata has raised approximately $45 million in disclosed equity funding across six rounds from 2014 through January 2021, with investors including Khosla Ventures, Intel Capital, Allegis Capital, Defy.vc, and strategic backers such as Blue Cross Blue Shield Association and Sandbox Industries. Leadership includes Dilawar Syed as President & CEO, with a Senior Director of Data Science and a Director of Customer Success on the team, indicating a composition weighted toward enterprise operations and technical depth.
Lumiata firmographics
Firmographics- Name
- Lumiata
- Website
- https://lumiata.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lumiata is a McLean, Virginia-based healthcare AI company that operates a value-based kidney and heart care management platform, serving health plans, providers, and patients through risk-sharing contracts and a proprietary decision-support technology.
- Ownership category
- akta.pro rank
Lumiata industry classification
Industry- Product category
- Healthcare AI Analytics
- NAICS
- Computer Systems Design and Related Services (54151), Other Scientific and Technical Consulting Services (541690), Social Assistance (624)
- SIC
- Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
- akta.pro secondary industries
- Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where Lumiata is headquartered
LocationHeadquarters
- HQ city
- Mclean
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Lumiata business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Distribution channels3 records
Marketing channels4 records
Lumiata product offering
Product offeringCore offering
Lumiata provides AI-powered analytics and decision-support technology for healthcare organizations to predict risk, manage costs, and improve outcomes at scale. The company operates a value-based care technology platform centered on its proprietary RenalIQ Technology Platform, which enables intelligent decision-making for kidney, heart, and broader population health management through integration and interoperability with healthcare data systems.
Differentiator
Problem solved
Functional benefit
Products and services
- RenalIQ Technology Platform
Quantifiable outcome
- Significantly reduced hospital admissions
- +2 more outcomes
Companies that use Lumiata
Customer profileSegments3 records
Ideal customer profiles1 record
Lumiata technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Lumiata partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Lumiata competitors and assessment
Company assessmentDirect peers
- InterWell Health: Value-based kidney care provider formed from Fresenius, Cricket Health, and InterWell — directly competes in the same risk-bearing kidney care contracts with health plans.
- Monogram Health: In-home kidney and polychronic care provider operating under value-based contracts with major health plans, using proprietary technology and local clinical teams — closely aligned with Lumiata's care-and-tech hybrid.
- Cricket Health: Kidney care company combining predictive analytics with multidisciplinary care teams under risk-bearing arrangements with payers — directly comparable AI-plus-care-team model.
- Somatus: Value-based kidney and heart care provider working with health plans through local care teams and proprietary technology — the most direct comparable to Lumiata's stated model in the kidney/cardiac value-based care category.
- Strive Health: Value-based kidney care company partnering with health plans and providers to deliver CKD/ESRD care, including home dialysis and transplant support — directly comparable services and customer base.
Emerging players
- ClosedLoop.ai: Healthcare-specific AI/ML platform for predictive risk and outcomes modeling — comparable AI technology layer, though Lumiata combines this with delivered clinical services.
- Olive AI: AI-driven healthcare automation platform targeting payers and providers with workflow and administrative intelligence — adjacent AI-for-healthcare play with overlapping buyer personas.
Broad incumbents
- WellSky: Health and community care technology and analytics company serving payers, providers, and care managers — broader incumbent with overlapping care management and population health capabilities.
- Health Catalyst: Healthcare data and analytics platform serving health systems and payers with population health and outcomes improvement capabilities — broader incumbent with overlapping data/analytics functionality.
- Lumeris: Value-based care enablement platform and services for health plans and providers, including population health and care management — broader incumbent serving similar payer/provider customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Lumiata social profiles
Digital presenceLumiata financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lumiata leadership team
Management profileNumber of profiles
Profiles3 records
Lumiata funding detail
Funding detailFunding overview
Funding rounds6 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lumiata M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lumiata
What does Lumiata do?
Lumiata provides AI-powered analytics and decision-support technology for healthcare organizations to predict risk, manage costs, and improve outcomes at scale. The company operates a value-based care technology platform centered on its proprietary RenalIQ Technology Platform, which enables intelligent decision-making for kidney, heart, and broader population health management through integration and interoperability with healthcare data systems.
Is Lumiata a public or private company?
Lumiata is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lumiata founded?
Lumiata was founded in 2013. It employs 11 to 50 people.
Where is Lumiata based?
Lumiata is headquartered in Mclean, United States, in the North America region.
Who are Lumiata's main competitors?
Direct peers on record are InterWell Health, Monogram Health, Cricket Health, Somatus and Strive Health. Emerging players are ClosedLoop.ai and Olive AI. Broad incumbents are WellSky, Health Catalyst and Lumeris.
Does Lumiata have an API?
No public API is recorded for Lumiata.
What industry is Lumiata in?
Lumiata's product category is Healthcare AI Analytics. Its primary akta.pro industry code is HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways), with a secondary code of HLALAFAC, Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support). Its NAICS code is 54151 and its SIC code is 8000.